News
The Creative Biogene division IntegrateRNA launched a novel platform that enables post-translational protein modification through the use of non-canonical amino acids and engineered transfer RNA. The ...
Scientists at Northwestern University and University of California, Santa Barbara have created the first synthetic fragment ...
Historically, bone has been recognized primarily for its structural role in the body, but emerging research suggests that it ...
Carterra Inc, a provider of innovative technologies, is partnering with ImmunoPrecise Antibodies (IPA), ACROBiosystems, and ...
Sangamo Therapeutics, Inc. , a genomic medicine company, today announced that the American Society of Gene & Cell Therapy (ASGCT) has accepted nine Sangamo abstracts for presentation at the 28th ASGCT ...
16h
The Print on MSNSpace farming to muscle regeneration, 7 experiments by Indian institutes to blast-off on Axiom-4Indian Astronaut-designate Shubhanshu Shukla will lead these experiments on India's behalf. Mission to lift-off from Kennedy ...
WALTHAM, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- ElevateBio, a technology-driven company focused on powering the creation of life-transforming genetic medicines, today announced presentations at the ...
Beyond conventional: Using advanced spectral solutions to expand single cell and population analysis
In today's fast-paced research environment, you need cutting-edge tools that push the boundaries of cellular analysis.
Taiwan Excellence welcomes the opportunity to introduce 15 leading Taiwanese brands at AUTOMATE 2025, the largest automation exhibition in North America, scheduled from May 12 ? 15 at Huntington Place ...
The Global Enteral Feeding Devices Market has demonstrated significant growth, valued at $2,828.52 million in 2019. It is projected to expand to $4,426.54 million by 2027, with a ...
Infectious diseases continue to pose major global health threats, with rising cases of antimicrobial resistance and the constant emergence of new pathogens.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results